Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Corticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of the adrenal cortex. The molecular pathogenesis of cortisol-producing adrenal adenomas is not well understood. METHODS: We performed exome sequencing of tumor-tissue specimens from 10 patients with cortisol-producing adrenal adenomas and evaluated recurrent mutations in candidate genes in an additional 171 patients with adrenocortical tumors. We also performed genomewide copy-number analysis in 35 patients with cortisol-secreting bilateral adrenal hyperplasias. We studied the effects of these genetic defects both clinically and in vitro. RESULTS: Exome sequencing revealed somatic mutations in PRKACA, which encodes the catalytic subunit of cyclic AMP-dependent protein kinase (protein kinase A [PKA]), in 8 of 10 adenomas (c.617A→C in 7 and c.595_596insCAC in 1). Overall, PRKACA somatic mutations were identified in 22 of 59 unilateral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable in 40 patients with subclinical hypercortisolism or in 82 patients with other adrenal tumors. Among 35 patients with cortisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number gain (duplication) of the genomic region on chromosome 19 that includes PRKACA. In vitro studies showed impaired inhibition of both PKA catalytic subunit mutants by the PKA regulatory subunit, whereas cells from patients with germline chromosomal gains showed increased protein levels of the PKA catalytic subunit; in both instances, basal PKA activity was increased. CONCLUSIONS: Genetic alterations of the catalytic subunit of PKA were found to be associated with human disease. Germline duplications of this gene resulted in bilateral adrenal hyperplasias, whereas somatic PRKACA mutations resulted in unilateral cortisol-producing adrenal adenomas. (Funded by the European Commission Seventh Framework Program and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic activating mutations of protein kinase A catalytic subunit (PRKACA) has been implicated in up to 50% of patients with adenomas with clinical Cushing’s syndrome, but not in adenomas producing less cortisol (138,142,147).”
From Adrenal incidentaloma (2020) · cites this paper as [147]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these mutations, the most frequently found (PKA-CL205R) is a point mutation leading to substitution of Leu at position 205 (or 206, depending on the convention used for numbering) with Arg and has been found in up to 67% of Cushing’s syndrome patients (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The L205R mutation was discovered independently in our laboratory and in other laboratories as the dominant genetic alteration in cortisol-producing adrenocortical adenomas responsible for Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Later on, our group and others discovered single mutations or insertions at the R/C interface that are linked to adrenal Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [38]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 1×
“Adrenal adenomas are common, with a prevalence of at least 3% among persons older than 50 years of age.(3) Whereas only a subset of these tumors is associated with overt Cushing’s syndrome, some degree of cortisol excess is present, depending on the diagnostic criteria applied,(4) in up to 47% of patients with adrenal…”
BackgroundThe clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Self-citationPersistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000172 · Cited by 574
Self-citationIncidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
Assembly of allosteric macromolecular switches: lessons from PKA
Taylor, S. S., Ilouz, R., Zhang, P., & Kornev, A. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3432 · Cited by 477
Research works printed but not linked: 1
- Bertherat J, 2003, Cancer Res, 63, 5308
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationGenomic spectra of biliary tract cancer
Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3375 · Cited by 1,284
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., Lerario, A. M., Else, T., Knijnenburg, T. A., Ciriello, G., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.002 · Cited by 657
“The high frequency of PRKAR1A mutations expands the role of PKA signaling in ACC and is consistent with PRKACA somatic mutations being the founder lesion of benign adrenal tumor associated with endocrinopathies such as Cushing syndrome (Beuschlein et al., 2014).”
InfluentialSelf-citationMutations in the deubiquitinase gene USP8 cause Cushing's disease
Reincke, M., Sbiera, S., Hayakawa, A., Theodoropoulou, M., Osswald, A., Beuschlein, F., Meitinger, T., Mizuno-Yamasaki, E., Kawaguchi, K., Saeki, Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3166 · Cited by 599
Self-citationCorrea, R., Salpea, P., & Stratakis, C. A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0209 · Cited by 378
Self-citationUncovering novel mutational signatures by de novo extraction with SigProfilerExtractor
Islam, S. M. A., Díaz-Gay, M., Wu, Y., Barnes, M., Vangara, R., Bergstrom, E. N., He, Y., Vella, M., Wang, J., Teague, J. W., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100179 · Cited by 365
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“Somatic activating mutations of protein kinase A catalytic subunit ( PRKACA ) has been implicated in up to 50% of patients with adenomas with clinical Cushing’s syndrome, but not in adenomas producing less cortisol (138,142,147).”
BackgroundOverview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Reincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Self-citationRecurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
Goh, G., Scholl, U. I., Healy, J. M., Choi, M., Prasad, M. L., Nelson-Williams, C., Kunstman, J. W., Korah, R., Suttorp, A.-C., Dietrich, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2956 · Cited by 251
Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology
Turnham, R. E., & Scott, J. D. (2016) · Gene · doi:10.1016/j.gene.2015.11.052 · Cited by 212
Recurrent somatic mutations underlie corticotropin-independent Cushing’s syndrome
Sato, Y., Maekawa, S., Ishii, R., Sanada, M., Morikawa, T., Shiraishi, Y., Yoshida, K., Nagata, Y., Sato-Otsubo, A., Yoshizato, T., et al. (2014) · Science · doi:10.1126/science.1252328 · Cited by 209
DNAJB1-PRKACA is specific for fibrolamellar carcinoma
Graham, R. P., Jin, L., Knutson, D. L., Kloft-Nelson, S. M., Greipp, P. T., Waldburger, N., Roessler, S., Longerich, T., Roberts, L. R., Oliveira, A. M., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.4 · Cited by 183
Activating mutations in CTNNB1 in aldosterone producing adenomas
Åkerström, T., Maharjan, R., Sven Willenberg, H., Cupisti, K., Ip, J., Moser, A., Stålberg, P., Robinson, B., Alexander Iwen, K., Dralle, H., et al. (2016) · Scientific Reports · doi:10.1038/srep19546 · Cited by 178
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome
James, K., Al-Ali, S., Tarn, J., Cockell, S. J., Gillespie, C. S., Hindmarsh, V., Locke, J., Mitchell, S., Lendrem, D., Bowman, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143970 · Cited by 177
MECHANISMS IN ENDOCRINOLOGY: Novel genetic causes of short stature
Wit, J. M., Oostdijk, W., Losekoot, M., van Duyvenvoorde, H. A., Ruivenkamp, C. A. L., & Kant, S. G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0937 · Cited by 177
Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks
Nanba, K., Omata, K., Gomez-Sanchez, C. E., Stratakis, C. A., Demidowich, A. P., Suzuki, M., Thompson, L. D. R., Cohen, D. L., Luther, J. M., Gellert, L., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12070 · Cited by 175
Self-citationPathogenesis and treatment of primary aldosteronism
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0382-4 · Cited by 174
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Zhang, H., Liu, Y., Liu, J., Chen, J., Wang, J., Hua, H. M., & Jiang, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01524-x · Cited by 172
Javorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab022 · Cited by 171
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
Forlino, A., Vetro, A., Garavelli, L., Ciccone, R., London, E., Stratakis, C. A., & Zuffardi, O. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1309730 · Cited by 171
Self-citationGadelha, M., Gatto, F., Wildemberg, L. E., & Fleseriu, M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01961-x · Cited by 168
Comprehensive pan-genomic characterization of adrenocortical carcinoma
Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., Lerario, A. M., Else, T., Knijnenburg, T. A., Ciriello, G., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.013 · Cited by 165
Self-citationChicard, M., Colmet-Daage, L., Clement, N., Danzon, A., Bohec, M., Bernard, V., Baulande, S., Bellini, A., Deveau, P., Pierron, G., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1586 · Cited by 148
Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Cushing’s syndrome: from physiological principles to diagnosis and clinical care
Raff, H., & Carroll, T. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.282871 · Cited by 137
Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas
Ronchi, C. L., Peverelli, E., Herterich, S., Weigand, I., Mantovani, G., Schwarzmayr, T., Sbiera, S., Allolio, B., Honegger, J. B., Appenzeller, S., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1064 · Cited by 123
Self-citationDi Dalmazi, G., Kisker, C., Calebiro, D., Mannelli, M., Canu, L., Arnaldi, G., Quinkler, M., Rayes, N., Tabarin, A., Laure Jullié, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2152 · Cited by 119
“None of the patients in this cohort were reported in our previous study (14).”
InfluentialSelf-citationWalker‐Gray, R., Stengel, F., & Gold, M. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701782114 · Cited by 116
Moody, S. E., Schinzel, A. C., Singh, S., Izzo, F., Strickland, M. R., Luo, L., Thomas, S. R., Boehm, J. S., Kim, S. Y., Wang, Z. C., et al. (2015) · Oncogene · doi:10.1038/onc.2014.153 · Cited by 112
Genetic Causes of Functional Adrenocortical Adenomas
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00189 · Cited by 111
Molecular Heterogeneity in Aldosterone-Producing Adenomas
Nanba, K., Chen, A., Omata, K., Vinco, M., Giordano, T. J., Else, T., Hammer, G. D., Tomlins, S. A., & Rainey, W. E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3239 · Cited by 105
Genetic mutations in sporadic pituitary adenomas—what to screen for?
Lecoq, A.-L., Kamenický, P., Guiochon‐Mantel, A., & Chanson, P. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.181 · Cited by 105
The regulation of PKA signaling in obesity and in the maintenance of metabolic health
London, E., & Stratakis, C. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108113 · Cited by 104
Self-citationBertherat, J. Y., Bourdeau, I., Bouys, L., Chasseloup, F., Kamenický, P., & Lacroix, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac034 · Cited by 100
Self-citationBerr, C. M., Di Dalmazi, G., Osswald, A., Ritzel, K., Bidlingmaier, M., Geyer, L. L., Treitl, M., Hallfeldt, K., Rachinger, W., Reisch, N., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3632 · Cited by 99
“However, recent genetic findings on cortisol-producing adenomas and clinical evidence from patients with adrenal incidentaloma argue against a transition from subclinical to clinical adrenal CS as a common mechanism of disease (25, 26).”
BackgroundSelf-citationAlbiger, N. M. E., Regazzo, D., Rubin, B., Ferrara, A. M., Rizzati, S., Taschin, E., Ceccato, F., Arnaldi, G., Giraldi, F. P., Stigliano, A., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0956-z · Cited by 99
Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas
Calebiro, D., Grassi, E., Eszlinger, M., Ronchi, C. L., Godbole, A., Bathon, K., Guizzardi, F., de Filippis, T., Krohn, K., Jaeschke, H., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84894 · Cited by 99
Self-citationPKA functions in metabolism and resistance to obesity: lessons from mouse and human studies
London, E., Bloyd, M., & Stratakis, C. A. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0035 · Cited by 99
Self-citationBourdeau, I., El Ghorayeb, N., Gagnon, N., & Lacroix, A. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0296 · Cited by 98
A genetic and molecular update on adrenocortical causes of Cushing syndrome
Lodish, M. B., & Stratakis, C. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.24 · Cited by 97
Self-citationRegulation of the adrenocortical stem cell niche: implications for disease
Walczak, E. M., & Hammer, G. D. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.166 · Cited by 95
The Molecular Basis for Specificity at the Level of the Protein Kinase a Catalytic Subunit
Søberg, K., & Skålhegg, B. S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00538 · Cited by 95
Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation
Ronchi, C. L., Di Dalmazi, G., Faillot, S., Sbiera, S., Assié, G., Weigand, I., Calebiro, D., Schwarzmayr, T., Appenzeller, S., Rubin, B., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1586 · Cited by 93
Self-citationActivating PRKACB somatic mutation in cortisol-producing adenomas
Espiard, S., Knape, M. J., Bathon, K., Assié, G., Rizk‐Rabin, M., Faillot, S., Rondof, W., Abid, D., Guignat, L., Calebiro, D., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98296 · Cited by 93
Self-citationMultiple aberrant hormone receptors in Cushing’s syndrome
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0200 · Cited by 90
Nieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 90
Coles, G. L., Cristea, S., Webber, J. T., Levin, R. S., Moss, S. M., He, A., Sangodkar, J., Hwang, Y. C., Arand, J., Drainas, A. P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.003 · Cited by 89
Genetic screening in arterial hypertension
Rossi, G. P., Ceolotto, G., Caroccia, B., & Lenzini, L. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.196 · Cited by 88
Structural insights into mis-regulation of protein kinase A in human tumors
Cheung, J., Ginter, C., Cassidy, M., Franklin, M. C., Rudolph, M. J., Robine, N., Darnell, R. B., & Hendrickson, W. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424206112 · Cited by 87
Diagnosis and management of primary bilateral macronodular adrenal hyperplasia
Vassiliadi, D. A., & Tsagarakis, S. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0240 · Cited by 87
Genetics of Acromegaly and Gigantism
Bogusławska, A., & Korbonits, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071377 · Cited by 87
Adrenal cortex renewal in health and disease
Lyraki, R., & Schedl, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00491-4 · Cited by 82
Ramms, D. J., Raimondi, F., Arang, N., Herberg, F. W., Taylor, S. S., & Gutkind, J. S. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000269 · Cited by 82
Bouys, L., & Bertherat, J. Y. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1120 · Cited by 81
Self-citationGenetics of tumors of the adrenal cortex
Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80
Self-citationCalebiro, D., Hannawacker, A., Lyga, S., Bathon, K., Zabel, U., Ronchi, C., Beuschlein, F., Reincke, M., Lorenz, K., Allolio, B., et al. (2014) · Nature Communications · doi:10.1038/ncomms6680 · Cited by 77
Self-citationAdrenocortical tumorigenesis: Lessons from genetics
Kamilaris, C. D. C., Hannah‐Shmouni, F., & Stratakis, C. A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101428 · Cited by 77
Self-citationPRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors
Berthon, A. S., Szarek, E., & Stratakis, C. A. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00026 · Cited by 75
Self-citationLodish, M. B., Yuan, B., Levy, I., Braunstein, G. D., Lyssikatos, C., Salpea, P., Szarek, E., Karageorgiadis, A. S., Belyavskaya, E., Raygada, M. J., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1154 · Cited by 74
Self-citationPrimary bilateral macronodular adrenal hyperplasia
De Venanzi, A., Alencar, G. A., Bourdeau, I., Fragoso, M. C. B. V., & Lacroix, A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000061 · Cited by 73
Lalli, E., & de Figueiredo, B. C. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00023 · Cited by 73
Juhlin, C. C., Bertherat, J. Y., Giordano, T. J., Hammer, G. D., Sasano, H., & Mete, Ö. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09667-0 · Cited by 73
Self-citationThiel, A., Reis, A.-C., Haase, M., Goh, G., Schott, M., Willenberg, H. S., & Scholl, U. I. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1113 · Cited by 72
Carney, J. A., Lyssikatos, C., Lodish, M. B., & Stratakis, C. A. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.09.005 · Cited by 72
Self-citationWalker, C., Wang, Y., Olivieri, C., Karamafrooz, A., Casby, J., Bathon, K., Calebiro, D., Gao, J., Bernlohr, D. A., Taylor, S. S., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw9298 · Cited by 71
Self-citationCreemers, S. G., Feelders, R. A., de Jong, F. H., Franssen, G. J. H., de Rijke, Y. B., van Koetsveld, P. M., & Hofland, L. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00217 · Cited by 70
Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing’s syndrome
Lecoq, A.-L., Stratakis, C. A., Viengchareun, S., Chaligné, R., Tosca, L., Deméocq, V., Hage, M., Berthon, A., Faucz, F. R., Hanna, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92184 · Cited by 66
Self-citationPredicting the prognosis of glioma by pyroptosis‐related signature
Chao, B., Jiang, F., Bai, H., Meng, P., Wang, L., & Wang, F. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17061 · Cited by 66
PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas
Rhayem, Y., Perez‐Rivas, L. G., Dietz, A., Bathon, K., Gebhard, C., Riester, A., Mauracher, B., Gómez-Sánchez, C. E., Eisenhofer, G., Schwarzmayr, T., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1700 · Cited by 64
Self-citationPrimary bilateral macronodular adrenal hyperplasia: definitely a genetic disease
Cavalcante, I. P., Berthon, A. S., Fragoso, M. C. B. V., Reincke, M., Stratakis, C. A., Ragazzon, B., & Bertherat, J. Y. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00718-y · Cited by 64
Self-citationENDOCRINE TUMOURS: The genomics of adrenocortical tumors
Faillot, S., & Assié, G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1118 · Cited by 64
Self-citationReincke, M., Albani, A., Assié, G., Bancos, I., Brue, T. C., Buchfelder, M., Chabre, O., Ceccato, F., Daniele, A., Detomas, M., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1088 · Cited by 61
Self-citationTurnham, R. E., Smith, F. D., Kenerson, H. L., Omar, M. H., Golkowski, M., Garcia, I., Bauer, R., Lau, H.-T., Sullivan, K. M., Langeberg, L. K., et al. (2019) · eLife · doi:10.7554/elife.44187 · Cited by 61
Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms
Lalazar, G., & Simon, S. (2018) · Seminars in Liver Disease · doi:10.1055/s-0037-1621710 · Cited by 61
Genetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 60
Drougat, L., Espiard, S., & Bertherat, J. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0532 · Cited by 60
Self-citationDrugs That Regulate Local Cell Signaling: AKAP Targeting as a Therapeutic Option
Bucko, P. J., & Scott, J. D. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022420-112134 · Cited by 60
Tabarin, A., Assié, G., Barat, P., Bonnet, F., Bonneville, J. F., Borson-Chazot, F., Bouligand, J., Boulin, A., Brue, T., Caron, P., et al. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.02.001 · Cited by 59
Self-citationSystematic identification of signal integration by protein kinase A
Filteau, M., Diss, G., Torres‐Quiroz, F., Dubé, A. K., Schraffl, A., Bachmann, V. A., Gagnon‐Arsenault, I., Chrétien, A.-È., Steunou, A., Dionne, U., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409938112 · Cited by 58
Genetics of Cushing’s Syndrome
Hernández-Ramírez, L. C., & Stratakis, C. A. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.007 · Cited by 57
Self-citationSun, N., Wu, Y., Nanba, K., Sbiera, S., Kircher, S., Kunzke, T., Aichler, M., Berezowska, S., Reibetanz, J., Rainey, W. E., et al. (2018) · Endocrinology · doi:10.1210/en.2018-00064 · Cited by 56
Self-citationRNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights
Dalmazi, G. D., Altieri, B., Scholz, C. J., Sbiera, S., Luconi, M., Waldman, J., Kaštelan, D., Ceccato, F., Chiodini, I., Arnaldi, G., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa616 · Cited by 56
Self-citationDeng, Z., Li, X., Ramírez, M. B., Purtell, K., Choi, I., Lu, J., Yu, Q., & Yue, Z. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020215118 · Cited by 55
Frequency and Clinical Correlates of Somatic Ying Yang 1 Mutations in Sporadic Insulinomas
Lichtenauer, U. D., Dalmazi, G. D., Slater, E. P., Wieland, T., Kuebart, A., Schmittfull, A., Schwarzmayr, T., Diener, S., Wiese, D., Thasler, W. E., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1100 · Cited by 55
Self-citationGermline and Mosaic Variants in PRKACA and PRKACB Cause a Multiple Congenital Malformation Syndrome
Palencia-Campos, A., Aoto, P. C., Machal, E. M. F., Rivera-Barahona, A., Soto-Bielicka, P., Bertinetti, D., Baker, B., Vu, L., Piceci-Sparascio, F., Torrente, I., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.09.005 · Cited by 55
Pathobiology and genetics of adrenocortical carcinoma
Pittaway, J. F. H., & Guasti, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0122 · Cited by 53
The Genetics of Adrenocortical Tumors
Espiard, S., & Bertherat, J. Y. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.004 · Cited by 53
Self-citationBimodal antagonism of PKA signalling by ARHGAP36
Eccles, R. L., Czajkowski, M. T., Barth, C., Müller, P. M., McShane, E., Grunwald, S., Beaudette, P., Mecklenburg, N., Volkmer, R., Zühlke, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12963 · Cited by 51
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
Favero, V., Cremaschi, A., Parazzoli, C., Falchetti, A., Gaudio, A., Gennari, L., Scillitani, A., Vescini, F., Morelli, V., Aresta, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020673 · Cited by 51
Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma
Riggle, K. M., Turnham, R., Scott, J. D., Yeung, R. S., & Riehle, K. J. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25970 · Cited by 51
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Castro, M. A., Corrales, E. P., Molina‐Cerrillo, J., & Alonso‐Gordoa, T. (2021) · Biomedicines · doi:10.3390/biomedicines9030304 · Cited by 50
Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma
Riggle, K. M., Riehle, K. J., Kenerson, H. L., Turnham, R., Homma, M. K., Kazami, M., Samelson, B., Bauer, R., McKnight, G. S., Scott, J. D., et al. (2016) · Pediatric Research · doi:10.1038/pr.2016.36 · Cited by 50
Fallo, F., Di Dalmazi, G., Beuschlein, F., Biermasz, N. R., Castinetti, F., Elenkova, A., Fassnacht, M., Isidori, A. M., Kastelan, D., Korbonits, M., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003252 · Cited by 49
Self-citationFeedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system
Rinaldi, L., Donne, R. D., Catalanotti, B., Torres‐Quesada, O., Enzler, F., Moraca, F., Nisticò, R., Chiuso, F., Piccinin, S., Bachmann, V. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10037-y · Cited by 49
Role of the endothelium and blood stasis in the development of varicose veins.
Michiels, C., Bouaziz, N., & Remacle, J. (2002) · PubMed · Cited by 49
Adrenocortical hyperplasia: A multifaceted disease
Bourdeau, I., Parisien-La Salle, S., & Lacroix, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101386 · Cited by 48
Clinicopathological correlates of adrenal Cushing's syndrome
Duan, K., Hernandez, K., & Mete, Ö. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202612 · Cited by 48
Diagnosis and Clinical Genetics of Cushing Syndrome in Pediatrics
Stratakis, C. A. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.006 · Cited by 47
Self-citation
Metadata
- Authors
- Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., Schaak, K., Schmittfull, A., Schwarzmayr, T., Barreau, O., Vezzosi, D., Rizk-Rabin, M., Zabel, U., Szarek, E., Salpea, P., Forlino, A., Vetro, A., Zuffardi, O., Kisker, C., Diener, S., Meitinger, T., Lohse, M. J., Reincke, M., Bertherat, J., Strom, T. M., & Allolio, B.
- Affiliations
- University of Würzburg (DE)
- Centre National de la Recherche Scientifique (FR)
- National Institutes of Health (US)
- Helmholtz Munich (DE)
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-03-13
- Volume
- 370
- Issue
- 11
- Pages
- 1019-1028
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4727447
- OpenAlex
- W2040816499
- Cited by
- 443
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 28 · 2023: 26 · 2022: 39 · 2021: 40 · 2020: 28 · 2019: 25 · 2018: 34 · 2017: 38 · 2016: 51 · 2015: 50 · 2014: 38
- FWCI
- 58.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- George Washington University
- Johns Hopkins University
- Cedars-Sinai Medical Center
- Quest Diagnostics
- Otsuka America
- European Commission (259735)
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD008920)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Cushing's syndrome, adrenal hyperplasia, PRKACA, protein kinase A catalytic subunit, somatic mutations, adrenocortical tumors, hypercortisolism
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Cushing Syndrome, Humans, Hydrocortisone, Middle Aged, Mutation, Protein Conformation, Sequence Analysis, DNA, Cyclic AMP-Dependent Protein Kinases, Germ-Line Mutation, Catalytic Domain, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.